Kailera Therapeutics

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Former Legend CEO lands at K2—Chutes & Ladders

Former Legend CEO lands at K2. VIB-spin off Tanai appoints new CEO. Transition at Bicara ahead of phase 2/3.
Yellow tape measure with a variety of weight loss medication on blue background

Kailera’s oral GLP-1 asset hits goals in Chinese phase 3 trials

Jul 7, 2026 8:44am
Bull market

Biotech IPOs here to stay after another record-breaking listing

Jun 12, 2026 11:00am
Money present

A new benchmark for biotech IPOs? Kailera raises $625M

Apr 17, 2026 4:42am
Injectable obesity weight loss

Kailera plans $528.5 million IPO to support obesity assets

Apr 13, 2026 1:10pm
Measuring tape on top of cash

Kailera plots IPO to fund Hengrui-licensed obesity pipeline

Mar 30, 2026 3:45am